Lenograstim

Lenograstim is a medication used to help stimulate the production of white blood cells. It is a type of medication known as a recombinant human granulocyte-colony stimulating factor (G-CSF). It is used to reduce the risk of infections in people with low white blood cell counts due to certain cancer treatments, such as chemotherapy and radiation therapy. Lenograstim is also used to treat severe chronic neutropenia (low white blood cell counts) in adults and children. It is given by subcutaneous injection under the skin or by intravenous infusion into a vein.

Lenograstim is a medication used to stimulate the production of white blood cells, specifically granulocytes. Here's a breakdown of its key points:

Function: Lenograstim, also known by the brand name Granocyte, belongs to a class of drugs called granulocyte colony-stimulating factors (G-CSFs). It works by mimicking the effects of a natural protein in the body called granulocyte-colony stimulating factor (G-CSF). G-CSF helps the bone marrow produce more white blood cells, particularly neutrophils, which are essential components of the immune system that fight infections.

Applications: Lenograstim is primarily used for the following purposes:

  • Increasing white blood cell counts after chemotherapy: Chemotherapy can suppress the bone marrow's ability to produce white blood cells, leaving patients more vulnerable to infections. Lenograstim helps to increase white blood cell counts after chemo, reducing the risk of infections.
  • Stem cell transplantation: In patients undergoing stem cell transplantation, Lenograstim can help mobilize stem cells from the bone marrow into the bloodstream for collection. These collected stem cells are then reintroduced into the patient after high-dose chemotherapy to help rebuild the immune system.
  • Severe chronic neutropenia: This is a condition characterized by a long-term decrease in the number of neutrophils. Lenograstim can help increase neutrophil counts in patients with severe chronic neutropenia, reducing their risk of infections.

Benefits:

  • Reduced risk of infections: By increasing white blood cell counts, Lenograstim helps the body fight infections more effectively, especially after chemotherapy or in cases of neutropenia.
  • Shorter hospital stays: In some cases, Lenograstim can help patients recover from chemotherapy faster and shorten hospital stays.
  • Mobilization of stem cells: It plays a crucial role in stem cell transplantation procedures by mobilizing stem cells for collection.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L03 Immunostimulants
L03A - Immunostimulants
L03AA Colony stimulating factors
External Links